logo
Is LASIK surgery dangerous? X user claims it made him ‘legally blind,' surgeon asked him to ‘to learn to live with it'

Is LASIK surgery dangerous? X user claims it made him ‘legally blind,' surgeon asked him to ‘to learn to live with it'

Hindustan Times18-05-2025
An X user revealed in a post, which is now viral, that he became 'legally blind' after his LASIK surgery. Chris Alvino detailed his ordeal, saying he was told that the only option was to 'learn to live with it.'
Alvino shared his experience in response to another post that read, 'Just asked a LASIK surgeon if he had any statistics about rates of complications at his clinic, or rates of patients reporting dry eyes 6 months out. He asked if I was a reporter (in a thick New York accent) and said no patient had ever asked for that before in 20 years.' The X account@birdpathy, which shared this post, added in the comment section, 'He did not have the statistics - he couldn't even say how many times he's performed different procedures. I said "I know everyone collects different stats" to give him an out. He said actually he "knows every surgeon in NYC" and none of them would know these numbers.'
Alvino shared @birdpathy's post, writing, 'I became legally blind after my LASIK surgery. And when my surgeon found out, he literally stopped talking to me during my appointment. He told me there was nothing we could do and I'd just have to learn to live with it. And offered zero follow up. Dude treated me like a pariah'.
He added in the comment section, 'So yeah, I'm not surprised these doctors and surgeons don't keep track of their complication rates. They're probably a shame on their massive ego, or maybe it's too much cognitive dissonance, knowing they are actively harming so many people'.
'But yeah, does THIS doctor's responses sound like something you'd hear from an ethical industry? Why are surgeons so scared to discuss complication rates for LASIK? Ask yourself this question next time you're considering the surgery,' he further wrote.
LASIK surgery, also known as laser-assisted in situ keratomileusis, is a kind of laser eye surgery aimed at reshaping the cornea to correct refractive errors like nearsightedness, farsightedness, and astigmatism. According to the American Academy of Ophthalmology, 'Research has shown that serious complications are rare and that the majority of patients are happy with the results.'
It added, 'The risks of LASIK have been studied extensively since the U.S. Food and Drug Administration (FDA) approved the surgery. According to the 2016 Modern LASIK Outcomes study, 99.5% of eyes saw 20/40 or better after LASIK. It's also true that a small number of patients have real, persistent side-effects after LASIK.'
Mayo Clinic says that complications resulting in a loss of vision are 'very rare.' However, some side effects are common, including 'dry eyes and temporary visual problems such as glare.' It added, 'These symptoms usually clear up after a few weeks or months. Few people consider them to be a long-term problem.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Top US vaccine official Vinay Prasad leaves agency 3 months after being appointed
Top US vaccine official Vinay Prasad leaves agency 3 months after being appointed

India Today

time3 hours ago

  • India Today

Top US vaccine official Vinay Prasad leaves agency 3 months after being appointed

The US Food and Drug Administration's (FDA) top vaccine official, Vinay Prasad, has left the agency after just three months as Director of the Centre for Biologics Evaluation and Research, a government spokesperson an oncologist who was a fierce critic of the US COVID-19 vaccine and mask mandates, was appointed in May by FDA Commissioner Marty Makary. Together they promised to speed regulatory action and pilot new review recent days, criticism of Prasad's tenure has intensified around the agency's handling of a gene therapy for Duchenne muscular dystrophy from Sarepta Therapeutics. The FDA-approved therapy played a role in the death of two teens who had advanced disease, and after a third death in a separate experimental gene therapy from the company, the FDA on July 18 asked Sarepta to stop all shipments of the approved DMD therapy, saying it had safety Loomer, a far-right activist and President Donald Trump ally, on July 20 posted a blog in which she called Prasad a "progressive leftist saboteur" who was undermining the agency's work. Loomer's critiques earlier this year led to the ouster of national security Monday, the Wall Street Journal's opinion section ran two pieces criticising Prasad, one of which called him a Bernie Sanders acolyte in MAHA drag, referring to the Trump administration's "Make America Healthy Again" movement. Both said he was not basing regulatory decisions on whether drugs helped patients, but on price."When he saw some of these sort of smear pieces, he didn't want to be a distraction," Makary said of Prasad's departure in an interview with CNBC on Tidmarsh, a former pharmaceutical executive who was recently appointed to lead the FDA's Center for Drug Evaluation and Research (CBER), will also be the acting CBER director, according to the agency's Department of Health and Human Services, which oversees the FDA, did not announce when the role would be permanently whose departure was announced late on Tuesday, did not immediately respond to a request for FDA on Monday changed course on Sarepta and said shipments to the main group of patients for the drug could changes under Prasad, who was also the agency's chief medical and science officer, included a new policy limiting the approval of COVID-19 vaccines, and his FDA division also rejected therapies from Replimmune and Capricor of Replimmune nearly doubled in value, while those of Sarepta and Capricor gained 11% and 18%, respectively, on and STAT news first reported Prasad's was a physician who joined the agency from the University of California, San Francisco. He has had stints at the National Cancer Institute and the National Institutes of FDA and other health agencies have seen multiple shakeups in recent months, under the leadership of US Health Secretary Robert F. Kennedy predecessor and long-time vaccine official at the FDA, Peter Marks, was ousted earlier this year, followed by gene therapy head Nicole Verdun."While another vacancy and another potential new face add uncertainty, we still think Prasad's departure is a net positive for the sector as many of our conversations have been overwhelmingly focused on regulatory risk and what he may or may not do," said Leerink analyst Joseph Schwartz.- EndsMust Watch IN THIS STORY#Donald Trump#White House#Covid-19

Karnataka collects 32.68 lakh litres of used oil; orders stricter checks on reuse, fortification
Karnataka collects 32.68 lakh litres of used oil; orders stricter checks on reuse, fortification

New Indian Express

time11 hours ago

  • New Indian Express

Karnataka collects 32.68 lakh litres of used oil; orders stricter checks on reuse, fortification

BENGALURU: In response to the collection of more than 32.68 lakh litres of used cooking oil across Karnataka over the last two years, the state Food Safety and Drug Administration (FDA) on Wednesday issued fresh directions to edible oil manufacturers, hotels, and bakeries to strengthen compliance with food safety norms. All cooking oil manufacturing units have now been directed to fortify their products with Vitamins A and D, maintain strict hygiene standards, and get their oils tested every six months. Proper labelling in line with FSSAI norms has also been made mandatory. The move, aimed at improving public health and preventing the unsafe reuse of oil, came during a state-wide video conference chaired by the Food Safety Commissioner. Officials reviewed the functioning of the Repurpose Used Cooking Oil (RUCO) initiative and flagged the need for more responsible handling of used oil.

Booze in energy cans: High Noon recalls vodka seltzer packs after dangerous mix-up
Booze in energy cans: High Noon recalls vodka seltzer packs after dangerous mix-up

Mint

time12 hours ago

  • Mint

Booze in energy cans: High Noon recalls vodka seltzer packs after dangerous mix-up

High Noon is recalling certain Beach Variety 12-packs after discovering some contain Celsius Astro Vibe energy drink cans filled with vodka seltzer, instead of non-alcoholic energy drinks. The mix-up happened when a packaging supplier accidentally shipped empty Celsius cans to High Noon's facility, where they were filled with the alcoholic beverage. Though labeled as Celsius Sparkling Blue Razz (with silver lids instead of standard black lids), these cans contain High Noon's 4.5% alcohol vodka seltzer, creating serious risks for children, pregnant women, or those avoiding alcohol for health or religious reasons. The affected products shipped to eight states between July 21-23: Florida, Michigan, New York, Ohio, Oklahoma, South Carolina, Virginia and Wisconsin . Consumers should check 12-pack lot codes printed on box exteriors: L CCC 17JL25 14:00 to 23:59 L CCC 18JL25 00:00 to 03:00 Individual Celsius cans with silver lids and bottom codes L CCB 02JL25 2:55 to 3:11 are also unsafe . No illnesses have been reported, but the FDA warns 'consumption will result in unintentional alcohol ingestion'.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store